BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Xu P, Luo A, Xiong C, Ren H, Yan L, Luo Q. SCUBE3 downregulation modulates hepatocellular carcinoma by inhibiting CCNE1 via TGFβ/PI3K/AKT/GSK3β pathway. Cancer Cell Int 2022;22:1. [PMID: 34980127 DOI: 10.1186/s12935-021-02402-z] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 18.0] [Reference Citation Analysis]
Number Citing Articles
1 Nasrolahi A, Azizidoost S, Radoszkiewicz K, Najafi S, Ghaedrahmati F, Anbiyaee O, Khoshnam SE, Farzaneh M, Uddin S. Signaling pathways governing glioma cancer stem cells behavior. Cellular Signalling 2023;101:110493. [DOI: 10.1016/j.cellsig.2022.110493] [Reference Citation Analysis]
2 Ding H, Zhang J, Zhang F, Xu Y, Liang W, Yu Y. Nanotechnological approaches for diagnosis and treatment of ovarian cancer: a review of recent trends. Drug Deliv 2022;29:3218-32. [PMID: 36259505 DOI: 10.1080/10717544.2022.2132032] [Reference Citation Analysis]
3 Azizidoost S, Nasrolahi A, Ghaedrahmati F, Kempisty B, Mozdziak P, Radoszkiewicz K, Farzaneh M. The pathogenic roles of lncRNA-Taurine upregulated 1 (TUG1) in colorectal cancer. Cancer Cell Int 2022;22:335. [DOI: 10.1186/s12935-022-02745-1] [Reference Citation Analysis]
4 Abdi E, Latifi-navid S. Emerging long noncoding RNA polymorphisms as novel predictors of survival in cancer. Pathology - Research and Practice 2022;239:154165. [DOI: 10.1016/j.prp.2022.154165] [Reference Citation Analysis]
5 Nasrolahi A, Azizidoost S, Radoszkiewicz K, Najafi S, Ghaedrahmati F, Sheykhi-sabzehpoush M, Poodineh J, Hajizadeh M, Anbiyaiee A, Farzaneh M, Feghhi M. Long non-coding RNAs involved in retinoblastoma. J Cancer Res Clin Oncol 2022. [DOI: 10.1007/s00432-022-04398-z] [Reference Citation Analysis]
6 Wang X, Wu S, Yang Y, Zhao J, Li G. LncRNA CARMN Affects Hepatocellular Carcinoma Prognosis by Regulating the miR-192-5p/LOXL2 Axis. Oxidative Medicine and Cellular Longevity 2022;2022:1-24. [DOI: 10.1155/2022/9277360] [Reference Citation Analysis]
7 Saikia M, Bhattacharyya DK, Kalita JK. CBDCEM: An effective centrality based differential co-expression method for critical gene finding. Gene Reports 2022. [DOI: 10.1016/j.genrep.2022.101688] [Reference Citation Analysis]
8 Farzaneh M, Najafi S, Dari MAG, Sheykhi-Sabzehpoush M, Dayer D, Cheraghzadeh M, Azizidoost S. Functional roles of long noncoding RNA MALAT1 in gynecologic cancers. Clin Transl Oncol 2022. [PMID: 36042115 DOI: 10.1007/s12094-022-02914-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Kong M, Yu X, Zheng Q, Zhang S, Guo W. Oncogenic roles of LINC01234 in various forms of human cancer. Biomed Pharmacother 2022;154:113570. [PMID: 36030582 DOI: 10.1016/j.biopha.2022.113570] [Reference Citation Analysis]
10 Azizidoost S, Ghaedrahmati F, Sheykhi-Sabzehpoush M, Uddin S, Ghafourian M, Mousavi Salehi A, Keivan M, Cheraghzadeh M, Nazeri Z, Farzaneh M, Khoshnam SE. The role of LncRNA MCM3AP-AS1 in human cancer. Clin Transl Oncol 2022. [PMID: 36002764 DOI: 10.1007/s12094-022-02904-w] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
11 Farzaneh M, Najafi S, Anbiyaee O, Azizidoost S, Khoshnam SE. LncRNA MALAT1-related signaling pathways in osteosarcoma. Clin Transl Oncol 2022. [PMID: 35790599 DOI: 10.1007/s12094-022-02876-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
12 Azizidoost S, Ghaedrahmati F, Anbiyaee O, Ahmad Ali R, Cheraghzadeh M, Farzaneh M. Emerging roles for lncRNA-NEAT1 in colorectal cancer. Cancer Cell Int 2022;22:209. [PMID: 35676702 DOI: 10.1186/s12935-022-02627-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
13 Anbiyaiee A, Ramazii M, Bajestani SS, Meybodi SM, Keivan M, Khoshnam SE, Farzaneh M. The function of LncRNA-ATB in cancer. Clin Transl Oncol 2022. [PMID: 35597865 DOI: 10.1007/s12094-022-02848-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
14 Shojaei Baghini S, Gardanova ZR, Abadi SAH, Zaman BA, İlhan A, Shomali N, Adili A, Moghaddar R, Yaseri AF. CRISPR/Cas9 application in cancer therapy: a pioneering genome editing tool. Cell Mol Biol Lett 2022;27:35. [PMID: 35508982 DOI: 10.1186/s11658-022-00336-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Rieser R, Menzen T, Biel M, Michalakis S, Winter G. Systematic studies on stabilization of AAV vector formulations by lyophilization. Journal of Pharmaceutical Sciences 2022. [DOI: 10.1016/j.xphs.2022.03.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
16 Büyükköroğlu G, Şenel B, Şalva E, Çalışkan B. Biotechnology applications in clinical trials. Biotechnology in Healthcare 2022. [DOI: 10.1016/b978-0-323-90042-3.00003-7] [Reference Citation Analysis]